For example, in approximately 40% of MG patients who are negative for anti-AChR antibodies, autoantibodies targeting the postsynaptic muscle-specific tyrosine kinase (MuSK) can be detected [17]. This evidence concerns the gene MUSK and myasthenia gravis.